<?xml version="1.0"?>

<document>
	<title>Inherited metabolic disease.</title>

	<author>Raine-D-N.</author>

	<source>Lancet. 1974 Oct 26. 2(7887). P 996-8.</source>

	<abstract>At present it is extremely doubtful if mass-population screening for
   any inherited metabolic disease other than phenylketonuria should be
   established beyond the few pilot studies at present in progress.  For
   many diseases, although early detection is clearly desirable or the
   technical means of screening are available, even the establishment of
   pilot surveys is not yet indicated.  Instead, methods of screening
   more limited populations at risk for particular disorders within a
   nationally coordinated administrative structure should be
   established.  Those with experience of mass screening for more than
   one inherited metabolic disease must surely be convinced that in new
   programmes launched prematurely the harm caused by incomplete
   detection of cases or recognition of disorders whose management is
   uncertain or unavailable can far outweigh any benefits.</abstract>

	<majorsubject>MASS-SCREENING</majorsubject>
	<majorsubject>METABOLISM-INBORN-ERRORS: di</majorsubject>

	<minorsubject>ALBUMINS: an</minorsubject>
	<minorsubject>AMINO-ACID-METABOLISM-INBORN-ERRORS: di</minorsubject>
	<minorsubject>CHROMATOGRAPHY: mt</minorsubject>
	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>COSTS-AND-COST-ANALYSIS</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: di, oc</minorsubject>
	<minorsubject>DIAGNOSIS-LABORATORY: mt</minorsubject>
	<minorsubject>EVALUATION-STUDIES</minorsubject>
	<minorsubject>IRON: du</minorsubject>
	<minorsubject>GALACTOSEMIA: di</minorsubject>
	<minorsubject>GENETIC-COUNSELING</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>HYPERLIPIDEMIA: di</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>INFANT-NEWBORN</minorsubject>
	<minorsubject>MECONIUM: an</minorsubject>
	<minorsubject>PHENYLALANINE: ur</minorsubject>
	<minorsubject>PHENYLKETONURIA:  di, oc, ur, bl</minorsubject>

	<reference>001   ANON                  BR MED J                         4     7 968</reference>
	<reference>002   WOOLF LI              PHENYLKETONURIA AND ALLIED ME         50 967</reference>
	<reference>003   GUTHRIE R             PEDIATRICS                      32   338 963</reference>
	<reference>004   KOMROWER GM           PROC R SOC MED                  61   296 968</reference>
	<reference>005   RAINE DN              BR MED J                         3     7 972</reference>
	<reference>006   MCKEOWN T             SCREENING IN MEDICAL CARE                968</reference>
	<reference>007   WHITBY LG             LANCET                           2   819 974</reference>
	<reference>008   RAINE DN              ANN CLIN BIOCHEM                 6    29 969</reference>
	<reference>009   PAPPWORTH MH          HUMAN GUINEA PIGS                     48 969</reference>
	<reference>010   FRANKLIN AW           BR MED J                         2   402 973</reference>
	<reference>011   BESSMAN SP            J PEDIATR                       69   334 966</reference>
	<reference>012   SMITH I               LANCET                           2   540 974</reference>
	<reference>013   RAINE DN              TREATMENT OF INHERITED ME                974</reference>
	<reference>014   GUTHRIE R             BIRTH DEF ORIG ART SER           4    92 968</reference>
	<reference>016   SHWACHMAN H           PEDIATRICS                      32    85 963</reference>
	<reference>017   HEROLD W              MONATSSCHR KINDERHEILKD        117   626 969</reference>
	<reference>018   GOLDBLOOM RB          N ENGL J MED                   269  1349 963</reference>
	<reference>019   WARWICK WJ            PEDIATRICS                      36   261 965</reference>
	<reference>020   PROSSER R             ARCH DIS CHILD                  49   597 974</reference>
	<reference>021   HELLSING K            SCAND J CLIN LAB INVEST         33   333 974</reference>
	<reference>022   GOLDSTEIN JL          J CLIN INVEST                   52  1533 973</reference>
	<reference>023   WESTWOOD A            IN: SENKINS WT                        63 973</reference>
	<reference>024   CARTER CO             LANCET                           1   281 971</reference>
	<reference>025   KELLER DF             G-6-PD DEFICIENCY                     47 971</reference>
	<reference>026   RAINE DN              BR MED J                         2   329 972</reference>
	<reference>027   KABACK MM             N ENGL J MED                   289  1090 973</reference>
	<reference>028   WHITTEN CF            N ENGL J MED                   288   318 973</reference>

	<citation>1   HOLLAND WW            LANCET                           2  1494 974</citation>
	<citation>2   BENKE PJ              PERSPECT BIOL MED               19   118 975</citation>
	<citation>3   CRAMPTON RF           BR MED BULL                     31   209 975</citation>
	<citation>4   BERRY HK              FED PROC                        34  2134 975</citation>
	<citation>5   MELLMAN WJ            ANN NY ACAD SCI                265   134 976</citation>
	<citation>6   CHALMERS RA           ANN CLIN BIOCHEM                14   149 977</citation>

</document>
